Trial reportEuropean journal of applied physiology2026
The effect of the pilates method on psychobiological factors and blood pressure in women with hypertension: a randomized controlled trial.
Trial report in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeThis study investigated the effects of a Pilates Method (PM) program including mat and apparatus-based exercises on psychobiological aspects and blood pressure (BP) in women with hypertension using antihypertensive medication.
methodsThis randomized controlled trial involved 28 women with hypertension (39–59 years) randomized into Control (CG = 14) or Pilates (PG = 14). The CG received usual care (continuing antihypertensive treatment and lifestyle guidance) without additional structured exercise training, while the PG underwent 55 min sessions, twice/week for 13 weeks. Psychobiological variables (anxiety, depression, stress, mood, attention, sleep quality, and health-related quality of life [HRQoL]) and BP were assessed pre/post using validated methods.
resultsThe PG significantly improved in depression, anxiety, and stress (all p < 0.001), with stress reduction greater than CG (p = 0.003). PG also improved in Pittsburgh Sleep Quality Index global score and most sleep components (p < 0.001 to p = 0.023), with between-group differences favoring PG. Mood states (tension, depression, vigor, fatigue) improved in PG (p < 0.001 to p = 0.002), all differing from CG except anger. PG showed faster attention time (p < 0.001) and fewer errors (p = 0.026), with a between-group difference for time (p < 0.001). HRQoL increased in PG (p = 0.012), with significant between-group differences (p = 0.001). PG reduced diastolic BP (p = 0.002) and mean BP (p = 0.002), while systolic BP decreased in both groups. CG showed no significant changes for most variables.
conclusionA 13-week PM program significantly improved anxiety, depression, stress, mood, attention, sleep quality, and HRQoL in women with hypertension using antihypertensive medications. Additionally, it promoted reductions in BP, supporting its role as a complementary non-pharmacological strategy.
Indexed as
Identifiers
41343071What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.